Company profile: ApiJect
1.1 - Company Overview
Company description
- Provider of a medical technology platform enabling scalable manufacturing and fill-finish of prefilled, single-dose injectors using Blow-Fill-Seal aseptic packaging. Offers the Prefilled ApiJect Injector with a pen needle–style hub; technology licensing for BFS mold/device design, development and production support; and design and engineering services for BFS fill-finish of temperature-sensitive biologics and vaccines.
Products and services
- ApiJect Platform: A modular technology system that integrates Blow-Fill-Seal aseptic packaging with attachable components, enabling pharmaceutical and biotech companies to create scalable prefilled injectors and fill-finish them with injectable drug products
- Prefilled ApiJect Injector: An aseptic-grade, prefilled single-dose delivery product that combines Blow-Fill-Seal aseptic drug packaging with a pen needle-style needle hub to administer injectable medicines
- Design & Engineering: Custom-engineered services that architect BFS fill-finish for temperature-sensitive biologics and vaccines, employing proprietary temperature management methods during development and process design
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ApiJect
PMG Research
HQ: United States
Website
- Description: Provider of integrated clinical research through a network of facilities operating from 12 U.S. metropolitan areas, conducting trials since 1979. Offerings include Accellacare studies on medical conditions such as migraines, post-surgical neuropathy, and COVID-19 vaccines; The Patient Voice feedback program; Lunch and Learn; and Tell a Friend referral program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMG Research company profile →
Humaneva
HQ: United States
Website
- Description: Provider of integrated clinical research solutions: Pratia, a network of clinical trial centers expanding patient access to innovative treatments, particularly in oncology; Kapadi, a CRO managing biotechnological oncology projects including gene and cell therapy research; and Hyggio, a clinical trial software platform with data analytics, eSource, CTMS, and remote monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Humaneva company profile →
Exela Pharma Sciences
HQ: United States
Website
- Description: Provider of sterile injectable pharmaceuticals for the healthcare sector, offering Sodium Bicarbonate Injection (electrolyte replenisher/systemic alkalizer), Caffeine Citrate Injection, ELCYS (cysteine hydrochloride injection), GLYRX-PF (synthetic anticholinergic), Nipride RTU (sodium nitroprusside), and Caffeine Citrate Oral Solution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exela Pharma Sciences company profile →
Pharmalog
HQ: Germany
Website
- Description: Provider of clinical research services as a clinical research organization, conducting Phase I and Phase II–IV trials for pharmaceutical and biotechnology companies, as well as non-interventional (NIS) studies. Offers research programs, special trials including dermatological/cosmetic studies, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmalog company profile →
Xpress Biologics
HQ: Belgium
Website
- Description: Provider of a large range of services from the design of expression systems to pre-clinical productions; as a One-Stop-Shop, also ensures the management of clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpress Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ApiJect
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ApiJect
2.2 - Growth funds investing in similar companies to ApiJect
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ApiJect
4.2 - Public trading comparable groups for ApiJect
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →